Skip to main content
TipRanks
Go Ultimate75% OFF

Tanvex Biopharma (TANVF) Revenue

6 Followers

Tanvex Biopharma Revenue

Tanvex Biopharma had a revenue of 220.44M in the quarter ending Jun 30, 2026, with 65.96%. This bring the company's revenue in the last twelve months to 657.56M, Increased 35.88%. In the fiscal year ending Dec 31, 2025, Tanvex Biopharma had annual revenue of 400.97M with 1056.27% growth.

Revenue (ttm)
657.56M
Revenue Growth
199.68%
P/S Ratio
0.57
Revenue/Employee
$1,864,981
Employees
215
Market Cap
$226.86M

Revenue Chart

Tanvex Biopharma Revenue - Annual

0100M200M300M400M500M300.00K5.41M22.40M61.41M34.68M400.97M201720182019202020212022202320242025
Revenue History
Download to Excel
TANVF revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025400.97M366.29M1056.27%
Dec 31, 202434.68M-26.73M-43.53%
Dec 31, 202361.41M39.01M174.11%
Dec 31, 202222.40M17.00M314.43%
Dec 31, 20215.41M5.11M1702.00%
Dec 31, 2020300.00K300.00K―
Dec 31, 20190.000.00―
Dec 31, 20180.000.00―
Dec 31, 20170.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
TANVF657.56M
ADMA519.15M
ANIP1.04B
EGRX257.55M
REGN16.90B
INCY6.01B